General MedicationsORALStandard
DARUNAVIR
DARUNAVIR
Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview DARUNAVIR is listed in Drugs@FDA under application 202136 (ANDA).
Marketing status: Prescription Active ingredient DARUNAVIR Form and strength TABLET;ORAL - 300MG Sponsor MYLAN Submission history Latest submission status date: 2025-07-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview DARUNAVIR is listed in Drugs@FDA under application 202136 (ANDA). Marketing status: Prescription Active ingredient DARUNAVIR Form and strength TABLET;ORAL - 300MG Sponsor MYLAN Submission history Latest submission status date: 2025-07-22 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.